Massimo Di Pietro

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Antonella Castagna, Franco Maggiolo, Giovanni Penco et al. · The Journal of Infectious Diseases · 2014 · 329 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Radiofrequency Ablation and Endoscopic Mucosal Resection for Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma: Outcomes of the UK National Halo RFA Registry

Rehan Haidry, Jason Dunn, Mohammed A. Butt et al. · Gastroenterology · 2013 · 232 citations · Full text

Medicine, Oncology, Surgery +16

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

Barbara Ensoli, Stefania Bellino, Antonella Tripiciano et al. · PLoS ONE · 2010 · 95 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quirós-Roldán et al. · Journal of Antimicrobial Chemotherapy · 2016 · 75 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Oral melanotic macules in patients infected with human immunodeficiency virus

Giuseppe Ficarra, Edward J. Shillitoe, Karen Adler‐Storthz et al. · Oral Surgery Oral Medicine Oral Pathology · 1990 · 63 citations

Dentistry, Oral Biology, Oral Pathology +14